Literature DB >> 25261926

Synthesis of IB-01212 by multiple N-methylations of peptide bonds.

Ryota Nabika1, Shinya Oishi2, Ryosuke Misu1, Hiroaki Ohno1, Nobutaka Fujii3.   

Abstract

There are many natural peptides with multiple N-methylamino acids that exhibit potent attractive biological activities. N-methylation of a peptide bond(s) is also one of the standard approaches in medicinal chemistry of bioactive peptides, to improve the potency and physicochemical properties, especially membrane permeability. In this study, we investigated a facile synthesis process of N-methylated peptides via simultaneous N-methylation of several peptide bonds in the presence of peptide bonds that were not to be methylated. As a model study, we investigated the synthesis of the antiproliferative depsipeptide, IB-01212. We used a pseudoproline to protect the non-methylated peptide bond during a simultaneous N-methylation with MeI-Ag2O. Using further manipulations including a dimerization/cyclization process, IB-01212 and its derivatives were successfully synthesized. A preliminary structure-activity relationship study demonstrated that the symmetric structure contributed to the potent cytotoxic activity of IB-01212.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Depsipeptide; Macrolactonization; N-Methylamino acid; N-methylation

Mesh:

Substances:

Year:  2014        PMID: 25261926     DOI: 10.1016/j.bmc.2014.08.036

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Total Synthesis and Biological Evaluation of Kakeromamide A and Its Analogues.

Authors:  Meng Zhao; Yi Xiao; Satoshi Otsuka; Yoichi Nakao; Yian Guo; Tao Ye
Journal:  Front Chem       Date:  2020-05-13       Impact factor: 5.221

2.  Total Synthesis of the Highly N-Methylated Peptides Carmabin A and Dragomabin.

Authors:  Baijun Ye; Peng Jiang; Tingrong Zhang; Yuanjun Sun; Xin Hao; Yingjun Cui; Liang Wang; Yue Chen
Journal:  Mar Drugs       Date:  2018-09-17       Impact factor: 5.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.